A Vaccine against Ebola Virus.
Journal: 2020/April - Cell
ISSN: 1097-4172
PUBMED: 32243796
Abstract:
Ervebo is the first licensed vaccine for prevention of Ebola virus disease. The vaccine, originally developed by the Public Health Agency of Canada, is delivered in a single 1 mL dose and has been delivered to >200,000 people in an ongoing 2018-2020 outbreak of disease. To view this Bench to Bedside, open or download the PDF.
Open in
Relations:
Citations
(7)
Diseases
(1)
Organisms
(1)
Affiliates
(1)
Similar articles
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.
Search and select entities to see details here. Details will include lists of related entities (via publication). Explore related entities further.